1
|
Moraes C, Varotto E, Artico M, Galassi FM, Forte F, Habicht ME. 3D facial approximation and endocast analysis of the Mummy of Minirdis (Ancient Egypt, ca. 2,300 Before Present). Morphologie 2024; 108:100781. [PMID: 38677263 DOI: 10.1016/j.morpho.2024.100781] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/19/2024] [Revised: 04/01/2024] [Accepted: 04/02/2024] [Indexed: 04/29/2024]
Abstract
The present article offers the facial approximation of the mummy of the ancient Egyptian adolescent named Minirdis (ca. 2300 years BP) by means of anatomical analysis of video-images and through a facial approximation protocol implemented on more historical personages. An evaluation of the mummy's endocast is also offered. A potential diagnosis of Sotos syndrome is cautiously considered but its inherent limitations are detailed. Finally, the methodology is presented as a valuable tool both for bio-historical research and for further studies on normal and pathologic morphologies of the cranio-facial district.
Collapse
Affiliation(s)
- C Moraes
- Arc-Team Brazil, Sinop-MT, Brazil
| | - E Varotto
- College of Humanities, Art and Social Sciences, Flinders University, Adelaide, SA, Australia
| | - M Artico
- Department of Sensory Organs, Policlinico Umberto I, Sapienza University of Rome, Rome, Italy
| | - F M Galassi
- Department of Anthropology, Faculty of Biology and Environmental Protection, University of Lodz, Lodz, Poland.
| | - F Forte
- Science Department, School of Pharmacy, Roma TRE University, Rome Italy & Urology Department, MG Vannini Hospital, Rome, Italy
| | - M E Habicht
- College of Humanities, Art and Social Sciences, Flinders University, Adelaide, SA, Australia
| |
Collapse
|
2
|
Salciccia S, Frisenda M, Tufano A, Di Pierro G, Bevilacqua G, Rosati D, Gobbi L, Basile G, Moriconi M, Mariotti G, Forte F, Carbone A, Pastore A, Cattarino S, Sciarra A, Gentilucci A. Intermittent Versus Continuous Androgen Deprivation Therapy for Biochemical Progression After Primary Therapy in Hormone-Sensitive Nonmetastatic Prostate Cancer: Comparative Analysis in Terms of CRPC-M0 Progression. Clin Genitourin Cancer 2024; 22:74-83. [PMID: 37758559 DOI: 10.1016/j.clgc.2023.08.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/04/2023] [Revised: 06/26/2023] [Accepted: 08/18/2023] [Indexed: 09/29/2023]
Abstract
INTRODUCTION To analyze whether the use of an intermittent (IAD) versus continuous (CAD) androgen deprivation therapy for the treatment of biochemical progression after primary treatments in prostate cancer can influence the development of nonmetastatic castration resistant prostate cancer (CRPC-M0). PATIENTS 170 male patients with an histologically confirmed diagnosis of PC, presenting a biochemical progression after primary treatments (82 after radical prostatectomy and 88 after external radiation therapy), nonmetastatic at imaging were considered for continuous (85 cases) or intermittent (85 cases) administration of androgen deprivation therapy. METHODS we retrospectively collect all data regarding histological diagnosis, primary treatment, imaging for M0-M1 staging, PSA at progression, time to biochemical progression from primary therapy, ADT used, IAD cycles, so to compare in 2 groups (IAD vs. CAD) time for progression from the beginning of ADT treatment and type of progression in terms of CRPC-M0 versus CRPC-M1 cases. RESULTS no significant (P= .4955) difference in the whole CRPC progression was found between IAD (25.8%) and CAD (30.5%) treatment at a mean of 32.7 ± 7.02 months and 35.6 ± 13.1 months respectively (P= .0738). Mean PSA at CRPC development was significantly higher in the IAD group (5.16 ± 0.68 ng/mL) than in the CAD group (3.1 ± 0.7 ng/mL) (P < .001). In all cases, imaging to detect M status at CRPC development was PET TC scan. At univariate analysis CAD administration significantly increases the RR for CRPC-M0 progression (RR 3.48; 95%CI 1.66-7.29; P = .01) when compared to the IAD administration, and this effect at multivariate analysis remained significant and independent to the other variables (RR 2.34, 95%CI 1.52-5.33; P = .03). CONCLUSIONS in our population with biochemical progression after primary treatment for PC, the intermittent administration of ADT significantly reduces the risk to develop CRPC-M0 disease when compared to a continuous administration of ADT, whereas no difference between the 2 strategies in terms of CRPC-M1 progression exists.
Collapse
Affiliation(s)
- Stefano Salciccia
- Department "Materno Infantile e Scienze Urologiche" University Sapienza, Rome, Italy
| | - Marco Frisenda
- Department "Materno Infantile e Scienze Urologiche" University Sapienza, Rome, Italy
| | - Antonio Tufano
- Department "Materno Infantile e Scienze Urologiche" University Sapienza, Rome, Italy
| | - Giovanni Di Pierro
- Department "Materno Infantile e Scienze Urologiche" University Sapienza, Rome, Italy
| | - Giulio Bevilacqua
- Department "Materno Infantile e Scienze Urologiche" University Sapienza, Rome, Italy
| | - Davide Rosati
- Department "Materno Infantile e Scienze Urologiche" University Sapienza, Rome, Italy
| | - Luca Gobbi
- Department "Materno Infantile e Scienze Urologiche" University Sapienza, Rome, Italy
| | - Greta Basile
- Department "Materno Infantile e Scienze Urologiche" University Sapienza, Rome, Italy
| | - Martina Moriconi
- Department "Materno Infantile e Scienze Urologiche" University Sapienza, Rome, Italy
| | - Gianna Mariotti
- Department "Materno Infantile e Scienze Urologiche" University Sapienza, Rome, Italy
| | | | - Antonio Carbone
- Department Urology, ICOT Center, University Sapienza, Latina, Italy
| | - Antonio Pastore
- Department Urology, ICOT Center, University Sapienza, Latina, Italy
| | | | | | | |
Collapse
|
3
|
Baldini E, Cardarelli S, Campese AF, Lori E, Fallahi P, Virili C, Forte F, Pironi D, Di Matteo FM, Palumbo P, Costanzo ML, D’Andrea V, Centanni M, Sorrenti S, Antonelli A, Ulisse S. Evaluation of the Therapeutic Effects of Harmine on Anaplastic Thyroid Cancer Cells. Int J Mol Sci 2024; 25:1121. [PMID: 38256193 PMCID: PMC10816100 DOI: 10.3390/ijms25021121] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/12/2023] [Revised: 01/11/2024] [Accepted: 01/12/2024] [Indexed: 01/24/2024] Open
Abstract
Anaplastic thyroid carcinoma (ATC) is an extremely difficult disease to tackle, with an overall patient survival of only a few months. The currently used therapeutic drugs, such as kinase inhibitors or immune checkpoint inhibitors, can prolong patient survival but fail to eradicate the tumor. In addition, the onset of drug resistance and adverse side-effects over time drastically reduce the chances of treatment. We recently showed that Twist1, a transcription factor involved in the epithelial mesenchymal transition (EMT), was strongly upregulated in ATC, and we wondered whether it might represent a therapeutic target in ATC patients. To investigate this hypothesis, the effects of harmine, a β-carboline alkaloid shown to induce degradation of the Twist1 protein and to possess antitumoral activity in different cancer types, were evaluated on two ATC-derived cell lines, BHT-101 and CAL-62. The results obtained demonstrated that, in both cell lines, harmine reduced the level of Twist1 protein and reverted the EMT, as suggested by the augmentation of E-cadherin and decrease in fibronectin expression. The drug also inhibited cell proliferation and migration in a dose-dependent manner and significantly reduced the anchorage-independent growth of both ATC cell lines. Harmine was also capable of inducing apoptosis in BHT-101 cells, but not in CAL-62 ones. Finally, the activation of PI3K/Akt signaling, but not that of the MAPK, was drastically reduced in treated cells. Overall, these in vitro data suggest that harmine could represent a new therapeutic option for ATC treatment.
Collapse
Affiliation(s)
- Enke Baldini
- Department of Surgery, “Sapienza” University of Rome, 00161 Rome, Italy; (E.B.); (S.C.); (E.L.); (D.P.); (F.M.D.M.); (P.P.); (M.L.C.); (V.D.); (S.S.)
| | - Silvia Cardarelli
- Department of Surgery, “Sapienza” University of Rome, 00161 Rome, Italy; (E.B.); (S.C.); (E.L.); (D.P.); (F.M.D.M.); (P.P.); (M.L.C.); (V.D.); (S.S.)
| | | | - Eleonora Lori
- Department of Surgery, “Sapienza” University of Rome, 00161 Rome, Italy; (E.B.); (S.C.); (E.L.); (D.P.); (F.M.D.M.); (P.P.); (M.L.C.); (V.D.); (S.S.)
| | - Poupak Fallahi
- Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, 56126 Pisa, Italy;
| | - Camilla Virili
- Department of Medico-Surgical Sciences and Biotechnologies, “Sapienza” University of Rome, 04100 Latina, Italy; (C.V.); (M.C.)
| | - Flavio Forte
- Department of Urology, M.G. Vannini Hospital, 00177 Rome, Italy;
| | - Daniele Pironi
- Department of Surgery, “Sapienza” University of Rome, 00161 Rome, Italy; (E.B.); (S.C.); (E.L.); (D.P.); (F.M.D.M.); (P.P.); (M.L.C.); (V.D.); (S.S.)
| | - Filippo Maria Di Matteo
- Department of Surgery, “Sapienza” University of Rome, 00161 Rome, Italy; (E.B.); (S.C.); (E.L.); (D.P.); (F.M.D.M.); (P.P.); (M.L.C.); (V.D.); (S.S.)
| | - Piergaspare Palumbo
- Department of Surgery, “Sapienza” University of Rome, 00161 Rome, Italy; (E.B.); (S.C.); (E.L.); (D.P.); (F.M.D.M.); (P.P.); (M.L.C.); (V.D.); (S.S.)
| | - Maria Ludovica Costanzo
- Department of Surgery, “Sapienza” University of Rome, 00161 Rome, Italy; (E.B.); (S.C.); (E.L.); (D.P.); (F.M.D.M.); (P.P.); (M.L.C.); (V.D.); (S.S.)
| | - Vito D’Andrea
- Department of Surgery, “Sapienza” University of Rome, 00161 Rome, Italy; (E.B.); (S.C.); (E.L.); (D.P.); (F.M.D.M.); (P.P.); (M.L.C.); (V.D.); (S.S.)
| | - Marco Centanni
- Department of Medico-Surgical Sciences and Biotechnologies, “Sapienza” University of Rome, 04100 Latina, Italy; (C.V.); (M.C.)
| | - Salvatore Sorrenti
- Department of Surgery, “Sapienza” University of Rome, 00161 Rome, Italy; (E.B.); (S.C.); (E.L.); (D.P.); (F.M.D.M.); (P.P.); (M.L.C.); (V.D.); (S.S.)
| | - Alessandro Antonelli
- Department of Surgical, Medical and Molecular Pathology and of Critical Area, University of Pisa, 56126 Pisa, Italy;
| | - Salvatore Ulisse
- Department of Surgery, “Sapienza” University of Rome, 00161 Rome, Italy; (E.B.); (S.C.); (E.L.); (D.P.); (F.M.D.M.); (P.P.); (M.L.C.); (V.D.); (S.S.)
| |
Collapse
|
4
|
Sciarra A, Santarelli V, Santodirocco L, Frisenda M, Salciccia S, Casale P, Forte F, Mariotti G, Moriconi M, Cattarino S, Sciarra B, Bevilacqua G, Gentilucci A. Is It Time to Anticipate the Use of PARP Inhibition in Prostate Cancer Patients? Curr Oncol 2023; 30:8054-8067. [PMID: 37754499 PMCID: PMC10528501 DOI: 10.3390/curroncol30090584] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/25/2023] [Revised: 08/28/2023] [Accepted: 08/29/2023] [Indexed: 09/28/2023] Open
Abstract
The increasing diffusion of genetic analysis regarding the pathogenetic variants (PVs) of genes involved in DNA Damage Repair (DDR) mechanisms and the development of Poly ADP ribose polymerase (PARP) inhibitors (PARPis) led to the first valid precision medicine option tailored toward metastatic prostate cancer (mPC). The concept of anticipation in the systemic treatment of mPC was initially adopted for androgen receptor signaling inhibitors (ARSIs) to describe the expansion of their indications, from the setting of the late-stage second-line treatment of metastatic castration-resistant prostate cancer (mCRPC) to first-line therapy in selected cases. There is already mounting evidence in favor of the anticipation of PARPis in the first line of mCRPC therapy, and further evidence in favor of mHSPC is emerging. Many studies have demonstrated the synergism between ARSIs and PARP inhibitors. Recent discoveries regarding the crosstalk between the androgen receptor (AR) and DNA repair mechanisms are disconnecting the use of PARPis from genetic analysis. The new message emerging is that the combination of PARPis with ARSIs may work independently of DDR mutational status. As a matter of fact, most of the recent trials analyzing the combination of PARPis with abiraterone or enzalutamide as a first-line therapy enrolled mCRPC patients irrespective of their mutational status. The PROPEL trial concluded that the advantage of the combination was independent of PV status, despite a higher advantage being reported in the BRCA1/2 mutated subgroup. The MAGNITUDE trial, however, showed a significant advantage only in the DDR mutated subgroup, and the DDR non-mutated cohort was closed for further enrollment. The combination of PARPis with ARSIs represents a significant strategy with a view to the anticipation and intensification of care in mPC. However, it should not nullify the advantages of precision medicine linked to the genetic analysis of DDR genes.
Collapse
Affiliation(s)
- Alessandro Sciarra
- Department Materno Infantile e Scienze Urologiche, University Sapienza, 00166 Rome, Italy; (V.S.); (L.S.); (M.F.); (S.S.); (G.M.); (M.M.); (S.C.); (G.B.); (A.G.)
| | - Valerio Santarelli
- Department Materno Infantile e Scienze Urologiche, University Sapienza, 00166 Rome, Italy; (V.S.); (L.S.); (M.F.); (S.S.); (G.M.); (M.M.); (S.C.); (G.B.); (A.G.)
| | - Lorenzo Santodirocco
- Department Materno Infantile e Scienze Urologiche, University Sapienza, 00166 Rome, Italy; (V.S.); (L.S.); (M.F.); (S.S.); (G.M.); (M.M.); (S.C.); (G.B.); (A.G.)
| | - Marco Frisenda
- Department Materno Infantile e Scienze Urologiche, University Sapienza, 00166 Rome, Italy; (V.S.); (L.S.); (M.F.); (S.S.); (G.M.); (M.M.); (S.C.); (G.B.); (A.G.)
| | - Stefano Salciccia
- Department Materno Infantile e Scienze Urologiche, University Sapienza, 00166 Rome, Italy; (V.S.); (L.S.); (M.F.); (S.S.); (G.M.); (M.M.); (S.C.); (G.B.); (A.G.)
| | - Paolo Casale
- Urologic Division, Humanitas Hospital, Rozzano, 00100 Milan, Italy;
| | - Flavio Forte
- Urologic Division, Figliesancamillo Hospital, 00198 Rome, Italy;
| | - Gianna Mariotti
- Department Materno Infantile e Scienze Urologiche, University Sapienza, 00166 Rome, Italy; (V.S.); (L.S.); (M.F.); (S.S.); (G.M.); (M.M.); (S.C.); (G.B.); (A.G.)
| | - Martina Moriconi
- Department Materno Infantile e Scienze Urologiche, University Sapienza, 00166 Rome, Italy; (V.S.); (L.S.); (M.F.); (S.S.); (G.M.); (M.M.); (S.C.); (G.B.); (A.G.)
| | - Susanna Cattarino
- Department Materno Infantile e Scienze Urologiche, University Sapienza, 00166 Rome, Italy; (V.S.); (L.S.); (M.F.); (S.S.); (G.M.); (M.M.); (S.C.); (G.B.); (A.G.)
| | - Beatrice Sciarra
- Department of Chemistry, University Sapienza, 00166 Rome, Italy;
| | - Giulio Bevilacqua
- Department Materno Infantile e Scienze Urologiche, University Sapienza, 00166 Rome, Italy; (V.S.); (L.S.); (M.F.); (S.S.); (G.M.); (M.M.); (S.C.); (G.B.); (A.G.)
| | - Alessandro Gentilucci
- Department Materno Infantile e Scienze Urologiche, University Sapienza, 00166 Rome, Italy; (V.S.); (L.S.); (M.F.); (S.S.); (G.M.); (M.M.); (S.C.); (G.B.); (A.G.)
| |
Collapse
|
5
|
Salciccia S, Frisenda M, Bevilacqua G, Gobbi L, Bucca B, Moriconi M, Viscuso P, Gentilucci A, Mariotti G, Cattarino S, Forte F, Fais S, Logozzi M, Sciarra B, Sciarra A. Exosome Analysis in Prostate Cancer: How They Can Improve Biomarkers' Performance. Curr Issues Mol Biol 2023; 45:6085-6096. [PMID: 37504300 PMCID: PMC10378661 DOI: 10.3390/cimb45070384] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/14/2023] [Revised: 07/15/2023] [Accepted: 07/19/2023] [Indexed: 07/29/2023] Open
Abstract
Exosomes are extracellular nanovesicles (EV), that is, carriers of different biomolecules such as lipids, proteins, nucleic acids. Their composition and the fact that their release dramatically increases in cases of tumorigenesis open up different scenarios on their possible application to research into new biomarkers. The first purpose of the present review was to specifically analyze and compare different methodologies available for the use of exosomes in prostate cancer (PC). The most widely applied methodologies include ultracentrifugation techniques, size-based techniques, immunoaffinity capture-based techniques (mainly ELISA), and precipitation. To optimize the acquisition of exosomes from the reference sample, more techniques can be applied in sequence for a single extraction, thereby determining an increase in labor time and costs. The second purpose was to describe clinical results obtained with the analysis of PSA-expressing exosomes in PC; this provides an incredibly accurate method of discriminating between healthy patients and those with prostate disease. Specifically, the IC-ELISA alone method achieved 98.57% sensitivity and 80.28% specificity in discriminating prostate cancer (PC) from benign prostatic hyperplasia (BPH). An immunocapture-based ELISA assay was performed to quantify and characterize carbonic anhydrase (CA) IX expression in exosomes. The results revealed that CA IX positive exosomes were 25-fold higher in plasma samples from PC patients than in those from healthy controls. The analysis of PC-linked exosomes represents a promising diagnostic model that can effectively distinguish patients with PC from those with non-malignant prostatic disease. However, the use of exosome analysis in clinical practice is currently limited by several issues, including a lack of standardization in the analytical process and high costs, which are still too high for large-scale use.
Collapse
Affiliation(s)
- Stefano Salciccia
- Department Materno Infantile Scienze Urologiche, University Sapienza, Viale Policlinico 155, 00161 Rome, Italy
| | - Marco Frisenda
- Department Materno Infantile Scienze Urologiche, University Sapienza, Viale Policlinico 155, 00161 Rome, Italy
| | - Giulio Bevilacqua
- Department Materno Infantile Scienze Urologiche, University Sapienza, Viale Policlinico 155, 00161 Rome, Italy
| | - Luca Gobbi
- Department Materno Infantile Scienze Urologiche, University Sapienza, Viale Policlinico 155, 00161 Rome, Italy
| | - Bruno Bucca
- Department Materno Infantile Scienze Urologiche, University Sapienza, Viale Policlinico 155, 00161 Rome, Italy
| | - Martina Moriconi
- Department Materno Infantile Scienze Urologiche, University Sapienza, Viale Policlinico 155, 00161 Rome, Italy
| | - Pietro Viscuso
- Department Materno Infantile Scienze Urologiche, University Sapienza, Viale Policlinico 155, 00161 Rome, Italy
| | - Alessandro Gentilucci
- Department Materno Infantile Scienze Urologiche, University Sapienza, Viale Policlinico 155, 00161 Rome, Italy
| | - Gianna Mariotti
- Department Materno Infantile Scienze Urologiche, University Sapienza, Viale Policlinico 155, 00161 Rome, Italy
| | - Susanna Cattarino
- Department Materno Infantile Scienze Urologiche, University Sapienza, Viale Policlinico 155, 00161 Rome, Italy
| | | | - Stefano Fais
- Istituto Superiore di Sanita, Viale Regina Elena, 00161 Rome, Italy
| | | | - Beatrice Sciarra
- Department of Chemistry, University Sapienza, Viale Universita, 00161 Rome, Italy
| | - Alessandro Sciarra
- Department Materno Infantile Scienze Urologiche, University Sapienza, Viale Policlinico 155, 00161 Rome, Italy
| |
Collapse
|
6
|
Forte F, Tripodi D, Pironi D, Corongiu E, Gagliardi F, Frisenda M, Gallo G, Quarantiello A, Di Lorenzo G, Cavaleri Y, Salciccia S, Lori E, Sorrenti S. Comparison of laparoscopic partial nephrectomy performed with AirSeal® system vs. standard insufflator: results from a referral center. Front Surg 2023; 10:1220332. [PMID: 37440928 PMCID: PMC10335758 DOI: 10.3389/fsurg.2023.1220332] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/10/2023] [Accepted: 06/13/2023] [Indexed: 07/15/2023] Open
Abstract
Objective To compare perioperative and oncologic surgical outcomes during laparoscopic partial nephrectomy (LPN) performed by standard carbon dioxide insufflation, with those from surgeries in which the AirSeal® intelligent insufflation system was used for renal tumors. Materials and methods A total of 27 patients with renal tumor were identified, 14 underwent LPN with AirSeal® (group A) and 13 LPN with standard insufflator (group B), respectively. Demographic baseline characteristics were similar in the two groups. Results The size of the tumor was largest in group B (29.64 vs. 32.1 mm). The mean operative time was shorter in the AirSeal® group [group A: mean 109.0 min, median 107.5 min, interquartile range (IQR) 85; group B: mean 121.0 min, median 120.0 min, IQR 50.0]. Positive margin rates were absent in the two groups. Estimated blood loss presented a difference in the perioperative period (group A: mean 1.5 g/dL, median 1.45 g/dL; group B: mean 2.15 g/dL, median 2.2 g/dL). Time to ischemia was found to be shorter in group A with a median of 18 min compared to a median of 20 min in group B. No subcutaneous emphysema, pneumothorax, and pneumomediastinum cases occurred in either group. A postoperative complication developed in one patient requiring superselective embolization. Conclusion In selected patients, our preliminary surgical experience has shown that the LPN procedure performed with the aid of the AirSeal® intelligent insufflation system can be used to treat even medium-/high-complexity kidney lesions, with a reduction in operating times, lower rates of complications, and perioperative blood loss. Clinical trial registration AirSealV1.
Collapse
Affiliation(s)
- Flavio Forte
- Department of Urology, M.G. Vannini Hospital, Rome, Italy
| | | | - Daniele Pironi
- Department of Surgery, Sapienza University of Rome, Rome, Italy
| | | | | | - Marco Frisenda
- Department of Urology, M.G. Vannini Hospital, Rome, Italy
| | - Gaetano Gallo
- Department of Surgery, Sapienza University of Rome, Rome, Italy
| | - Antonia Quarantiello
- Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy
| | - Giuseppe Di Lorenzo
- Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy
| | - Yuri Cavaleri
- Department of Urology, San Giovanni Battista Hospital, Foligno, Italy
| | - Stefano Salciccia
- Department of Maternal-Infant and Urological Sciences, Sapienza University of Rome, Rome, Italy
| | - Eleonora Lori
- Department of Surgery, Sapienza University of Rome, Rome, Italy
| | | |
Collapse
|
7
|
Gagliardi F, Lauro A, De Anna L, Tripodi D, Esposito A, Forte F, Pironi D, Lori E, Gentile PA, Marino IR, Figueroa ET, D'Andrea V. The Risk of Malignant Degeneration of Müllerian Derivatives in PMDS: A Review of the Literature. J Clin Med 2023; 12:jcm12093115. [PMID: 37176556 PMCID: PMC10179332 DOI: 10.3390/jcm12093115] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/20/2023] [Revised: 03/21/2023] [Accepted: 04/18/2023] [Indexed: 05/15/2023] Open
Abstract
Persistent Müllerian Duct Syndrome (PMDS) is a rare autosomal recessive disorder of sex development characterized by the presence of fallopian tubes, uterus and upper one-third of the vagina in individuals with XY genotype and normal male phenotype. The main complications of PMDS are infertility and the rare risk of malignant degeneration of both testicular and Müllerian derivatives. We report the case of a 49-year-old man who, during repair of an incisional hernia, was incidentally found to have a uterine-like structure posterior to the bladder. In the past at the age of 18 months, he had undergone bilateral orchidopexies for bilateral cryptorchidism. The intraoperative decision was to preserve the uterine-like structure and make a more accurate diagnosis postoperatively. Evaluation revealed an XY chromosome and imaging consistent with PMDS. The patient was informed about the risk of neoplastic transformation of the residual Müller ducts and was offered surgical treatment, which he declined. Subsequent follow-up imaging studies, including testicular and pelvic ultrasound, were negative for findings suggestive of malignant testicular and Mullerian derivative degeneration. A review of the international literature showed that, when a decision is taken to remove the Mullerian derivatives, laparoscopy and especially robotic surgery allow for the successful removal of Müllerian derivatives. Whenever the removal of these structures is not possible or the patient refuses to undergo surgery, it is necessary to inform the patient of the need for adequate follow-up. Patients should undergo regular pelvic imaging examination and MRI might be a better method for that purpose.
Collapse
Affiliation(s)
| | - Augusto Lauro
- Department of Surgery, Sapienza University of Rome, 00161 Rome, Italy
| | - Livia De Anna
- Department of Surgery, Sapienza University of Rome, 00161 Rome, Italy
| | - Domenico Tripodi
- Department of Surgery, Sapienza University of Rome, 00161 Rome, Italy
| | - Anna Esposito
- Department of Surgery, Sapienza University of Rome, 00161 Rome, Italy
| | - Flavio Forte
- Urology Department, M.G. Vannini Hospital, 00177 Rome, Italy
| | - Daniele Pironi
- Department of Surgery, Sapienza University of Rome, 00161 Rome, Italy
| | - Eleonora Lori
- Department of Surgery, Sapienza University of Rome, 00161 Rome, Italy
| | | | - Ignazio R Marino
- Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA 19107, USA
| | - Ernesto T Figueroa
- Division of Pediatric Urology, Nemours/Alfred I. DuPont Hospital for Children, Wilmington, DE 19803, USA
| | - Vito D'Andrea
- Department of Surgery, Sapienza University of Rome, 00161 Rome, Italy
| |
Collapse
|
8
|
Bellini MI, Lori E, Forte F, Lauro A, Tripodi D, Amabile MI, Cantisani V, Varanese M, Ferent IC, Baldini E, Ulisse S, D’Andrea V, Pironi D, Sorrenti S. Thyroid and renal cancers: A bidirectional association. Front Oncol 2022; 12:951976. [PMID: 36212468 PMCID: PMC9538481 DOI: 10.3389/fonc.2022.951976] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/24/2022] [Accepted: 08/22/2022] [Indexed: 12/01/2022] Open
Abstract
There is a deep interrelation between the thyroid gland and the kidney parenchyma, with dysfunction of the first leading to significant changes in renal metabolism and vice versa. Given the recognition of cancer as a systemic disease, the raise of thyroid tumors and the common association of several malignancies, such as breast cancer, prostate cancer, colorectal cancer, and other, with an increased risk of kidney disease, public health alert for these conditions is warranted. A systematic review of the current evidence on the bidirectional relationship between thyroid and renal cancers was conducted including 18 studies, highlighting patient’s characteristics, histology, time for secondary malignancy to develop from the first diagnosis, treatment, and follow-up. A total of 776 patients were identified; median age was 64 years (range: 7–76 years). Obesity and family history were identified as the most common risk factors, and genetic susceptibility was suggested with a potential strong association with Cowden syndrome. Controversy on chemo and radiotherapy effects was found, as not all patients were previously exposed to these treatments. Men were more likely to develop kidney cancer after a primary thyroid malignancy, with 423/776 (54%) experiencing renal disease secondarily. Median time after the first malignancy was 5.2 years (range: 0–20 years). With the advancement of current oncological therapy, the prognosis for thyroid cancer patients has improved, although there has been a corresponding rise in the incidence of multiple secondary malignancy within the same population, particularly concerning the kidney. Surgery can achieve disease-free survival, if surveillance follow-up allows for an early localized form, where radical treatment is recommended.
Collapse
Affiliation(s)
- Maria Irene Bellini
- Department of Surgical Sciences, Sapienza University of Rome, Rome, Italy
- *Correspondence: Maria Irene Bellini,
| | - Eleonora Lori
- Department of Surgical Sciences, Sapienza University of Rome, Rome, Italy
| | - Flavio Forte
- Department of Urology, M. G. Vannini Hospital, Rome, Italy
| | - Augusto Lauro
- Department of Surgical Sciences, Sapienza University of Rome, Rome, Italy
| | - Domenico Tripodi
- Department of Surgical Sciences, Sapienza University of Rome, Rome, Italy
| | - Maria Ida Amabile
- Department of Surgical Sciences, Sapienza University of Rome, Rome, Italy
| | - Vito Cantisani
- Department of Radiological, Anatomopathological and Oncological Sciences, Sapienza University of Rome, Rome, Italy
| | - Marzia Varanese
- Department of Surgical Sciences, Sapienza University of Rome, Rome, Italy
| | | | - Enke Baldini
- Department of Surgical Sciences, Sapienza University of Rome, Rome, Italy
| | - Salvatore Ulisse
- Department of Surgical Sciences, Sapienza University of Rome, Rome, Italy
| | - Vito D’Andrea
- Department of Surgical Sciences, Sapienza University of Rome, Rome, Italy
| | - Daniele Pironi
- Department of Surgical Sciences, Sapienza University of Rome, Rome, Italy
| | - Salvatore Sorrenti
- Department of Surgical Sciences, Sapienza University of Rome, Rome, Italy
| |
Collapse
|
9
|
Ulisse S, Baldini E, Pironi D, Gagliardi F, Tripodi D, Lauro A, Carbotta S, Tarroni D, D’Armiento M, Morrone A, Forte F, Frattaroli F, Persechino S, Odorisio T, D’Andrea V, Lori E, Sorrenti S. Is Melanoma Progression Affected by Thyroid Diseases? Int J Mol Sci 2022; 23:ijms231710036. [PMID: 36077430 PMCID: PMC9456309 DOI: 10.3390/ijms231710036] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/29/2022] [Revised: 08/25/2022] [Accepted: 08/31/2022] [Indexed: 11/16/2022] Open
Abstract
Clinical and epidemiological evidence indicate a relationship between thyroid diseases and melanoma. In particular, the hypothyroidism condition appears to promote melanoma spread, which suggests a protective role of thyroid hormones against disease progression. In addition, experimental data suggest that, in addition to thyroid hormones, other hormonal players of the hypothalamic–pituitary–thyroid (HPT) axis, namely the thyrotropin releasing hormone and the thyrotropin, are likely to affect melanoma cells behavior. This information warrants further clinical and experimental studies in order to build a precise pattern of action of the HPT hormones on melanoma cells. An improved knowledge of the involved molecular mechanism(s) could lead to a better and possibly personalized clinical management of these patients.
Collapse
Affiliation(s)
- Salvatore Ulisse
- Department of Surgical Sciences, “Sapienza” University of Rome, 00161 Rome, Italy
- Correspondence:
| | - Enke Baldini
- Department of Surgical Sciences, “Sapienza” University of Rome, 00161 Rome, Italy
| | - Daniele Pironi
- Department of Surgical Sciences, “Sapienza” University of Rome, 00161 Rome, Italy
| | - Federica Gagliardi
- Department of Surgical Sciences, “Sapienza” University of Rome, 00161 Rome, Italy
| | - Domenico Tripodi
- Department of Surgical Sciences, “Sapienza” University of Rome, 00161 Rome, Italy
| | - Augusto Lauro
- Department of Surgical Sciences, “Sapienza” University of Rome, 00161 Rome, Italy
| | - Sabino Carbotta
- Department of Surgical Sciences, “Sapienza” University of Rome, 00161 Rome, Italy
| | - Danilo Tarroni
- Department of Surgical Sciences, “Sapienza” University of Rome, 00161 Rome, Italy
| | - Matteo D’Armiento
- Scientific Direction, IRCCS San Gallicano Dermatological Institute, 00144 Rome, Italy
| | - Aldo Morrone
- Scientific Direction, IRCCS San Gallicano Dermatological Institute, 00144 Rome, Italy
| | - Flavio Forte
- Urology Department, M.G. Vannini Hospital, 00177 Rome, Italy
| | - Flaminia Frattaroli
- Department of Surgical Sciences, “Sapienza” University of Rome, 00161 Rome, Italy
| | - Severino Persechino
- Department of Neurosciences, Mental Health and Sensory Organs, “Sapienza” University of Rome, 00161 Rome, Italy
| | - Teresa Odorisio
- Laboratory of Molecular and Cell Biology, Istituto Dermopatico dell’Immacolata, IDI-IRCCS, 00167 Rome, Italy
| | - Vito D’Andrea
- Department of Surgical Sciences, “Sapienza” University of Rome, 00161 Rome, Italy
| | - Eleonora Lori
- Department of Surgical Sciences, “Sapienza” University of Rome, 00161 Rome, Italy
| | - Salvatore Sorrenti
- Department of Surgical Sciences, “Sapienza” University of Rome, 00161 Rome, Italy
| |
Collapse
|
10
|
Porter D, Forte F, Granata V, Cannavacciuolo M, Fittipaldi R, Cuoco M, Bombardi A, Vecchione A. Guiding antiferromagnetic transitions in Ca 2RuO 4. Acta Cryst Sect A 2022. [DOI: 10.1107/s2053273322091732] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 03/19/2023]
|
11
|
Cefalù A, D'Erasmo L, Giammanco A, Montali A, Iannuzzo G, Zambon A, Forte F, Noto D, Suppressa P, Giannini S, Arca M, Averna M. Lomitapide effectively reduces triglyceride (TG) levels in familial chylomicronemia syndrome (FCS). Atherosclerosis 2022. [DOI: 10.1016/j.atherosclerosis.2022.06.214] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/02/2022]
|
12
|
Porter DG, Forte F, Granata V, Cannavacciuolo M, Fittipaldi R, Cuoco M, Bombardi A, Vecchione A. Guiding antiferromagnetic transitions in Ca[Formula: see text]RuO[Formula: see text]. Sci Rep 2022; 12:10957. [PMID: 35768497 PMCID: PMC9242999 DOI: 10.1038/s41598-022-14932-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/19/2022] [Accepted: 06/15/2022] [Indexed: 11/09/2022] Open
Abstract
Understanding and controlling the transition between antiferromagnetic states having different symmetry content with respect to time-inversion and space-group operations are fundamental challenges for the design of magnetic phases with topologically nontrivial character. Here, we consider a paradigmatic antiferromagnetic oxide insulator, Ca[Formula: see text]RuO[Formula: see text], with symmetrically distinct magnetic ground states and unveil a novel path to guide the transition between them. The magnetic changeover results from structural and orbital reconstruction at the transition metal site that in turn arise as a consequence of substitutional doping. By means of resonant X-ray diffraction we track the evolution of the structural, magnetic, and orbital degrees of freedom for Mn doped Ca[Formula: see text]RuO[Formula: see text] to demonstrate the mechanisms which drive the antiferromagnetic transition. While our analysis focuses on a specific case of substitution, we show that any perturbation that can impact in a similar way on the crystal structure, by reconstructing the induced spin-orbital exchange, is able to drive the antiferromagnetic reorganization.
Collapse
Affiliation(s)
- D. G. Porter
- Diamond Light Source Ltd., Harwell Science and Innovation Campus, Didcot, Oxfordshire OX11 0DE UK
| | - F. Forte
- CNR-SPIN, c/o Universitá di Salerno-Via Giovanni Paolo II, 132-84084 Fisciano, SA Italy
- Dipartimento di Fisica ‘E.R. Caianiello’, Universitá di Salerno, 84084 Fisciano, Salerno Italy
| | - V. Granata
- Dipartimento di Fisica ‘E.R. Caianiello’, Universitá di Salerno, 84084 Fisciano, Salerno Italy
| | - M. Cannavacciuolo
- Dipartimento di Fisica ‘E.R. Caianiello’, Universitá di Salerno, 84084 Fisciano, Salerno Italy
| | - R. Fittipaldi
- CNR-SPIN, c/o Universitá di Salerno-Via Giovanni Paolo II, 132-84084 Fisciano, SA Italy
- Dipartimento di Fisica ‘E.R. Caianiello’, Universitá di Salerno, 84084 Fisciano, Salerno Italy
| | - M. Cuoco
- CNR-SPIN, c/o Universitá di Salerno-Via Giovanni Paolo II, 132-84084 Fisciano, SA Italy
- Dipartimento di Fisica ‘E.R. Caianiello’, Universitá di Salerno, 84084 Fisciano, Salerno Italy
| | - A. Bombardi
- Diamond Light Source Ltd., Harwell Science and Innovation Campus, Didcot, Oxfordshire OX11 0DE UK
- Department of Physics, University of Oxford, Parks Road, Oxford, OX1 3PU UK
| | - A. Vecchione
- CNR-SPIN, c/o Universitá di Salerno-Via Giovanni Paolo II, 132-84084 Fisciano, SA Italy
- Dipartimento di Fisica ‘E.R. Caianiello’, Universitá di Salerno, 84084 Fisciano, Salerno Italy
| |
Collapse
|
13
|
Gagliardi F, Lauro A, Tripodi D, Amabile MI, Palumbo P, Di Matteo FM, Palazzini G, Forte F, Frattaroli S, Khouzam S, Marino IR, D'Andrea V, Sorrenti S, Pironi D. Mesenteric Cyst with GI Symptoms: A Fluid Approach to Treatment-Case Report and Literature Review. Dig Dis Sci 2022; 67:786-798. [PMID: 35059952 DOI: 10.1007/s10620-021-07352-0] [Citation(s) in RCA: 6] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 11/17/2021] [Indexed: 12/09/2022]
Abstract
Mesenteric cysts are defined as a heterogeneous group of intra-abdominal cystic lesions of the mesentery or omentum that may be found in any portion of the gastrointestinal tract from the duodenum to the rectum. The clinical condition is entirely asymptomatic in many patients, particularly with small cysts. The diagnosis is typically incidental and secondary to imaging performed for other purposes. In symptomatic patients, the clinical picture is characterized by nonspecific gastrointestinal signs and symptoms. Treatment may be surgical or via interventional radiology. We report the case of a 55-year-old female patient complaining of left-sided abdominal discomfort and constipation lasting three months. An abdominal ultrasound showed the presence of a 10 × 14 × 16 cm anechoic cystic mass filling the whole anterior and left abdominal cavity, confirmed by CT and MRI. The cyst, removed laparoscopically, was histologically a simple mesothelial cyst. We reviewed the international literature over the last 10 years of all cases with mesenteric cysts > 10 cm in evaluating gastrointestinal symptoms at diagnosis, histology, performed treatment, and outcome.
Collapse
Affiliation(s)
- Federica Gagliardi
- Department of Surgical Sciences, Sapienza University of Rome, Viale Regina Elena 324, 00161, Rome, Italy
| | - Augusto Lauro
- Department of Surgical Sciences, Sapienza University of Rome, Viale Regina Elena 324, 00161, Rome, Italy
| | - Domenico Tripodi
- Department of Surgical Sciences, Sapienza University of Rome, Viale Regina Elena 324, 00161, Rome, Italy.
| | - Maria Ida Amabile
- Department of Surgical Sciences, Sapienza University of Rome, Viale Regina Elena 324, 00161, Rome, Italy
| | - Piergaspare Palumbo
- Department of Surgical Sciences, Sapienza University of Rome, Viale Regina Elena 324, 00161, Rome, Italy
| | - Filippo Maria Di Matteo
- Department of Surgical Sciences, Sapienza University of Rome, Viale Regina Elena 324, 00161, Rome, Italy
| | - Giorgio Palazzini
- Department of Surgical Sciences, Sapienza University of Rome, Viale Regina Elena 324, 00161, Rome, Italy
| | - Flavio Forte
- Urology Department, M.G. Vannini Hospital, Rome, Italy
| | - Stefano Frattaroli
- Department of Surgical Sciences, Sapienza University of Rome, Viale Regina Elena 324, 00161, Rome, Italy
| | - Simone Khouzam
- Department of Surgery, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, USA
| | - Ignazio R Marino
- Department of Surgery, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, USA
| | - Vito D'Andrea
- Department of Surgical Sciences, Sapienza University of Rome, Viale Regina Elena 324, 00161, Rome, Italy
| | - Salvatore Sorrenti
- Department of Surgical Sciences, Sapienza University of Rome, Viale Regina Elena 324, 00161, Rome, Italy
| | - Daniele Pironi
- Department of Surgical Sciences, Sapienza University of Rome, Viale Regina Elena 324, 00161, Rome, Italy
| |
Collapse
|
14
|
Calcaterra I, Gentile M, Iannuzzo G, Tripaldella M, Di Minno A, Forte F, Buonaiuto A, Di Taranto M, Rubba P, Di Minno M. Changes in carotid stiffness in patients with familial hypercholesterolemia treated with evolocumab®: A prospective cohort study. Atherosclerosis 2020. [DOI: 10.1016/j.atherosclerosis.2020.10.866] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
15
|
Buonaiuto A, Gentile M, Calcaterra I, Giacobbe C, Tripaldella M, Forte F, Di Minno M, Iannuzzo G, Fortunato G, Rubba P. Correlation between different LDL-R mutations and response to AB-PCSK9 therapy in a group of patient with genetic diagnosis of familial hypercholesterolemia. Atherosclerosis 2020. [DOI: 10.1016/j.atherosclerosis.2020.10.162] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
16
|
Calcaterra I, Di Minno A, Gentile M, Tripaldella M, Buonaiuto A, Forte F, Di Taranto M, Giacobbe C, Iannuzzo G, Rubba P, Di Minno M. Changes in markers of subclinical atherosclerosis in patients with familial hypercholesterolemia treated with evolocumab: a prospective cohort study. Eur Heart J 2020. [DOI: 10.1093/ehjci/ehaa946.3347] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
PCSK-9-i demonstrated efficacy in cholesterol reduction and prevention of cardiovascular events.
Purpose
Changes in lipid-profile, oxidative stress and subclinical atherosclerosis markers in patients with familial hypercholesterolemia (FH) during 12 weeks of treatment with PCSK-9-i.
Methods
Patients with FH starting a treatment with Evolocumab® were included. TC, LDL-C, Lp(a), small dense LDL (assessed byLDL score), 11-dehydro-thromboxane (11-TXB2), 8-iso-prostaglandin-2alpha (8-iso-PGF2α),FMD, RHI and carotid stiffness were evaluated at baseline and after 12weeks of treatment.
Results
25 subjects were enrolled (52% males, mean age 51.5 years). At the 12-week, the median reduction was 38% for TC, 52% for LDL-C, 7% for Lp(a) and 46% for LDL score; 11-TXB2 and 8-iso-PGF2α were reduced of 18% and 17%, respectively. FMD changed from4.78%±2.27 to10.6%±5.89 (p<0.001), with RHI changing from 2.37±1.23 to 3.76±1.36 (p<0.001). Carotid stiffness changed from 8.8 (IQR: 7.0–10.4)m/sec to 6.6 m/sec (IQR: 5.4–7.5), p<0.001). At a multivariate analysis, changes in LDL score predicted changes in FMD (β=−0.846, p=0.015) in carotid stiffness (β=0.429, p=0.041), and in 8-iso-PGF2α (β=0.778, p=0.012).
Conclusions
Small dense LDL reduction is related to changes in oxidative stress and in subclinical atherosclerosis markers in FH patients treated with Evolocumab®.
Changes in endothelial function
Funding Acknowledgement
Type of funding source: None
Collapse
Affiliation(s)
| | - A Di Minno
- Federico II University Hospital, Naples, Italy
| | - M Gentile
- Federico II University Hospital, Naples, Italy
| | | | - A Buonaiuto
- Federico II University Hospital, Naples, Italy
| | - F Forte
- Federico II University Hospital, Naples, Italy
| | | | - C Giacobbe
- Federico II University Hospital, Naples, Italy
| | - G Iannuzzo
- Federico II University Hospital, Naples, Italy
| | - P.O.F Rubba
- Federico II University Hospital, Naples, Italy
| | | |
Collapse
|
17
|
Buonaiuto A, Gentile M, Calcaterra I, Giacobbe C, Tripaldella M, Forte F, Iannuzzo G, Di Minno M, Fortunato G, Rubba P. Correlation between different LDL-R mutations and response to ab-PCSK9 therapy in a group of patient with genetic diagnosis of Familial Hypercholesterolemia. Preliminary report. Eur Heart J 2020. [DOI: 10.1093/ehjci/ehaa946.3332] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Introduction
Familial hypercholesterolemia (FH) is an autosomal dominant disease that leads to premature cardiovascular disease (CAD). The availability of ab-PCSK9 has changed the approach to therapy.
Purpose
To evaluate the relationship between different types of mutations in LDLR gene and response to ab-PCSK9.
Methods
73 FH patients, 33 women and 40 men (53.9±13. yrs), in primary prevention (N=46) and secondary prevention (N=27), were recruited. This sample included patients with mutations in LDLR gene: heterozygotes for missense mutations (N=31), for null mutations (N=31), compound heterozygotes or homozygotes (N=11). At baseline, the whole sample had a maximally tolerated lipid lowering therapy (MT-LLT) without ab-PCSK9; 16 patients had MT-LLTs intolerance. After 160 days with ab-PCSK9 therapy we evaluated the achievement of a goal (LDL-C<70 mg/dL in primary prevention without Diabetes Mellitus, LDL-C<55 mg/dL).
Results
After 160 days of therapy with ab-PCSK9 (45 patients on Alirocumab, 28 patients on Evolocumab) and MT-LLT, 29/73 patients (39.7%) of the whole sample achieve the goal of LDL-C. Of them 14/29 (48.2%) were in primary prevention, 15/29 (51.7%) in secondary prevention, no difference in achievement of the goal. We then evaluated the percent of patients achieving the goal of LDL-C:
15/31 (48.3%) patients with missense mutation and 14/31 (45.1%) patients with null mutation, no significant difference among groups;
0/11 compound heterozygotes or homozygotes;
3/16 (18.7%) MT-LLTs intolerance.
The other main cardiovascular risk factors did not influence of the achievement the goal of LDL cholesterol.
Conclusions
Lack of correlation between type of mutation in heterozygous FH patients and ab-PCSK9 therapy response; response was significantly poorest in patients with compound heterozygosis or homozygosis mutation as compared to heterozygotes; the intolerance to MT-LLT was significant in the achievement of the goal of LDL-C.
Different between guideline 2016 vs 2019
Funding Acknowledgement
Type of funding source: None
Collapse
Affiliation(s)
- A Buonaiuto
- ASL Napoli 1 Centre, Dipartimento di Medicina Clinica e Chirurgia, Università “Federico II” di Napoli, Napoli, Italy, Napoli, Italy
| | - M Gentile
- ASL Napoli 1 Centre, Dipartimento di Medicina Clinica e Chirurgia, Università “Federico II” di Napoli, Napoli, Italy, Napoli, Italy
| | - I.L Calcaterra
- ASL Napoli 1 Centre, Dipartimento di Medicina Clinica e Chirurgia, Università “Federico II” di Napoli, Napoli, Italy, Napoli, Italy
| | - C Giacobbe
- ASL Napoli 1 Centre, 2Dipartimento di Medicina molecolare e Biotecnologie mediche, Università “Federico II” di Napoli, Na, Napoli, Italy
| | - M Tripaldella
- ASL Napoli 1 Centre, Dipartimento di Medicina Clinica e Chirurgia, Università “Federico II” di Napoli, Napoli, Italy, Napoli, Italy
| | - F Forte
- ASL Napoli 1 Centre, Dipartimento di Medicina Clinica e Chirurgia, Università “Federico II” di Napoli, Napoli, Italy, Napoli, Italy
| | - G Iannuzzo
- ASL Napoli 1 Centre, Dipartimento di Medicina Clinica e Chirurgia, Università “Federico II” di Napoli, Napoli, Italy, Napoli, Italy
| | - M.N.D Di Minno
- ASL Napoli 1 Centre, Dipartimento di Medicina Clinica e Chirurgia, Università “Federico II” di Napoli, Napoli, Italy, Napoli, Italy
| | - G Fortunato
- ASL Napoli 1 Centre, 2Dipartimento di Medicina molecolare e Biotecnologie mediche, Università “Federico II” di Napoli, Na, Napoli, Italy
| | - P.O.F Rubba
- ASL Napoli 1 Centre, Dipartimento di Medicina Clinica e Chirurgia, Università “Federico II” di Napoli, Napoli, Italy, Napoli, Italy
| |
Collapse
|
18
|
Olivieri V, Ruggiero G, Abate D, Serra N, Fortunati V, Griffa D, Forte F, Corongiu E. Fatal infections in andrology. Atypical clinical presentation of a Fournier's disease. Arch Ital Urol Androl 2020; 92. [PMID: 33016049 DOI: 10.4081/aiua.2020.3.213] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/29/2019] [Accepted: 03/27/2020] [Indexed: 11/23/2022] Open
Abstract
BACKGROUND Fournier disease (FD) is a worrisome infection of genital area caused by a polimicrobial infection and characterized by a rapid progression to necrosis. Scrotum, perineum and lower abdomen represent the primary sites of origin. Clinical presentation and laboratory strongly suggest FD, but if not precociously diagnosed, it may quickly evolve into septic syndrome and patient's death. CASE REPORT A 62 years old Caucasian male presented for fever and penile gross oedema recently occurred. No history of previous urinary tract infection, hematuria or genital trauma was referred. He did not complain any storage or voiding low urinary tract symptom (LUTS); no foci of infection in genitoperineal area was observed nor urethral discharge. The ultrasound (US) revealed a disomogeneous broad thickening of subcutaneous tissues with increased vascularity on Color-Doppler. When the penis was manipulated in order to reduce oedema, retract foreskin and evaluate the glans, clinical parametres rapidly worsened and the patient developed a septic shock with blood pressure falling down, dyspnoea and tachyarrhythmia, and he was fastly sent to Intensive Care Unit where it has been hemodynamically stabilized and subjected to antibiotic therapy. Considering the clinical absence of gangrene's foci, we opted for a conservative treatment by maintaining bladder catheter and drug therapy.
Collapse
Affiliation(s)
- Valerio Olivieri
- Division of Urology, Ivrea civil Hospital (ASL TO4), Ivrea (Turin).
| | | | | | | | | | | | | | | |
Collapse
|
19
|
Olivieri V, Fortunati V, Bellei L, Massarelli M, Ruggiero G, Abate D, Serra N, Griffa D, Forte F, Corongiu E. Primary small-cell neuroendocrine carcinoma of the bladder: Case report and literature review. ACTA ACUST UNITED AC 2020; 92. [PMID: 33016048 DOI: 10.4081/aiua.2020.3.211] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/29/2019] [Accepted: 03/27/2020] [Indexed: 11/23/2022]
Abstract
BACKGROUND Neuroendocrine tumours (NET) are extremely rare and aggressive. Although they commonly affect intestine, many organs may be involved such as pancreas, lung or urinary tract. Bladder is rarely involved. Actually, two main forms of bladder NET have been described: small-cell and large-cell. The first one is considered highly agressive since it shows poor oncologic outcomes being mainly diagnosed at advanced stage: the second one is extremely rare and equally aggressive. CASE REPORT A 78-years-old Caucasian male presented to our facility for lower urinary tract symptoms and gross hematuria recently occurred. He was a strong smoker since many years. No familiarity for urothelial cancer was referred nor previous episodes of hematuria until that time. Citology was negative; outpatient ultrasound of the bladder revealed a 3 cm bladder thickening highly suspicious for bladder cancer; patient underwent TC scan that confirmed the bladder lesion. A transurethral resection of the bladder (TURB) was performed. After 3 months total body TC showed multiple visceral metastases also involving brain and lymph nodes. Best supportive care was offered but the patient died 6 months later. RESULTS Pathology revealed a mixed bladder tumor: 30% of the specimen resulted as an high-grade urothelial cancer (G3) and 70% as small-cell neuroendocrine variant.Microscopic muscle involvement was excluded. CONCLUSIONS Neuroendocrine tumors are uncommon entities which origin from cells of neuro-endocrine system and may potentially involve all human tissues. Neuroendocrine smallcell carcinoma of the bladder is a non-urothelial histotype: it is highly aggressive and diagnosed mainly at advanced stages. Whenever considering the high risk of metastatic spread and the poor prognosis, a multimodal approach is highly suggested. TURB alone is uneffective in disease control due to its aggressive nature. Unless metastatic, radical cystectomy and adjuvant chemotherapy represent the gold standard.
Collapse
|
20
|
Corongiu E, Grande P, Liberati E, Iacovelli R, Amini M, Mascioli P, Pagliarella G, Squillacciotti S, Di Santo A, Zampelli A, Forte F, Olivieri V. Clear Cell carcinoma of the urinary bladder, A case report: Surgical and oncological management. Arch Ital Urol Androl 2020. [DOI: 10.4081/aiua.2020.3.217] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
Abstract
Introduction: Bladder cancer is a condition characterized by a broad spectrum of histological variants and clinical courses. The morphological description of histological variants is becoming increasingly important. The 75% of cases of these cancers are classified as pure urothelial carcinoma, while the remaining 25% is represented by other histological variants. The clear cell carcinoma is part of urothelial group and is a very rare entity. Oncological outcomes of this variant are still uncertain, but seems to be worst than for patiens with pure urothelial carcinoma. Moreover it seems to metastasize more easily to the lymph nodes. Case report: We present a case of a Caucasian 73 year old woman who, after an episode of gross hematuria, underwent an ultrasound of the urinary system, a cystoscopy and a total body computed tomography (CT) which confirmed the presence of a bladder neoformation. A transurethral resection of the bladder (TURB) was performed: the result of the histological examination was "poorly differentiated clear cell carcinoma". Given the rarity of histological characterization, we required a PET CT scan for more accurate staging, at which a suspected right pelvic lymph node was detected. We proposed a radical cystectomy with hysteroannessiectomy and extended lymphadenectomy. During the pre-hospitalization process, the patient developed anuria, with acute renal failure and bilateral hydronephrosis, which required the placement of bilateral nephrostomies; we performed the planned surgical procedure and the histological exam confirmed: high grade urothelial carcinoma with a high percentage (more than 70%) of clear cell carcinoma, with a strong local aggression and lymphnode metastates. We referred the patient to the oncologist who suggested a treatment plan within an immunotherapy based clinical trial and cisplatin. Conclusions: The morphological description of histological variants in bladder cancer is gaining increasing importance, especially for infiltrating and aggressive forms. The clear cell carcinoma is a very rare entity part of the urothelial group; they would seem more aggressive forms with an early lymph node involvement. This evidence is confirmed by the clinical case described, in which we have seen a large local aggression with an involvement of the lymph nodes of the right side of the pelvis of the pre-sacral ones. In these cases, the multimodal approach is crucial.
Collapse
|
21
|
Corongiu E, Grande P, Liberati E, Iacovelli R, Amini M, Mascioli P, Pagliarella G, Squillacciotti S, Di Santo A, Zampelli A, Forte F, Olivieri V. Clear Cell carcinoma of the urinary bladder, A case report: Surgical and oncological management. ACTA ACUST UNITED AC 2020; 92. [PMID: 33016051 DOI: 10.4081/aiua.2020.3.218] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/07/2020] [Accepted: 06/06/2020] [Indexed: 11/23/2022]
Abstract
INTRODUCTION Bladder cancer is a condition characterized by a broad spectrum of histological variants and clinical courses. The morphological description of histological variants is becoming increasingly important. The 75% of cases of these cancers are classified as pure urothelial carcinoma, while the remaining 25% is represented by other histological variants. The clear cell carcinoma is part of urothelial group and is a very rare entity. Oncological outcomes of this variant are still uncertain, but seems to be worst than for patiens with pure urothelial carcinoma. Moreover it seems to metastasize more easily to the lymph nodes. CASE REPORT We present a case of a Caucasian 73 year old woman who, after an episode of gross hematuria, underwent an ultrasound of the urinary system, a cystoscopy and a total body computed tomography (CT) which confirmed the presence of a bladder neoformation. A transurethral resection of the bladder (TURB) was performed: the result of the histological examination was "poorly differentiated clear cell carcinoma". Given the rarity of histological characterization, we required a PET CT scan for more accurate staging, at which a suspected right pelvic lymph node was detected. We proposed a radical cystectomy with hysteroannessiectomy and extended lymphadenectomy. During the pre-hospitalization process, the patient developed anuria, with acute renal failure and bilateral hydronephrosis, which required the placement of bilateral nephrostomies; we performed the planned surgical procedure and the histological exam confirmed: high grade urothelial carcinoma with a high percentage (more than 70%) of clear cell carcinoma, with a strong local aggression and lymphnode metastates. We referred the patient to the oncologist who suggested a treatment plan within an immunotherapy based clinical trial and cisplatin. CONCLUSIONS The morphological description of histological variants in bladder cancer is gaining increasing importance, especially for infiltrating and aggressive forms. The clear cell carcinoma is a very rare entity part of the urothelial group; they would seem more aggressive forms with an early lymph node involvement. This evidence is confirmed by the clinical case described, in which we have seen a large local aggression with an involvement of the lymph nodes of the right side of the pelvis of the pre-sacral ones. In these cases, the multimodal approach is crucial.
Collapse
|
22
|
Stephens G, O’Neill S, Clifford C, Cuff A, Forte F, Hawthorn C, Littlewood C. Greater trochanteric pain syndrome in the UK national health service: a multi-centre service evaluation. Physiotherapy 2020. [DOI: 10.1016/j.physio.2020.03.242] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
23
|
Corongiu E, Grande P, Di Santo A, Pagliarella G, Squillacciotti S, Liberati E, Zampelli A, Olivieri V, Innocenzi M, Forte F. Safety and efficacy of retroperitoneal sutureless zero ischemia laparoscopic partial nephrectomy for low nephrometry score masses. ACTA ACUST UNITED AC 2019; 91. [PMID: 31577100 DOI: 10.4081/aiua.2019.3.157] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/12/2019] [Accepted: 07/21/2019] [Indexed: 11/23/2022]
Abstract
OBJECTIVES To evaluate oncological feasibility and oncological and functional results of retroperitoneal sutureless zero ischemia laparoscopic partial nephrectomy (LPN). PATIENTS AND METHODS Patients with posterior renal masses with low nephrometry score (RENAL ≤ 7) treated who underwent retroperitoneal sutureless zero ischemia.in a single center from January 2016 to November 2017. Clinical, surgical and pathological data were prospectively collected. Complications were reported according to the modified Clavien classification. RESULTS Retroperitoneal sutureless zero ischemia laparoscopic partial nephrectomy was performed on 15 patients. The indication for nephron-sparing surgery was elective in 11 (73%) patients and imperative in 4 (27%). Median RENAL score was 5 (IQR: 5-7), median tumor diameter 25 mm (IQR: 20-35). In 11 cases, the tumor was located polar (85%), and in 2 cases hilar (15%). There were no intraoperative complications. No cases were converted to radical nephrectomy, and in no case parenchyma suture was necessary. Median operative time was 90 min (IQR:40-150), in no case clamping of the renal artery was necessary, median hospital stay was 4 days, median estimated blood loss (EBL) was 310 (180-500) ml. Pathological analysis showed renal cell carcinoma in 11 patients (85%), 9 (60%) staged T1a and 2 (13%) T1b. In 4 (27%) an oncocytoma was found. There were no positive surgical margins. One patient developed a major postoperative complication (postoperative renal bleeding requiring super-selective embolization). Trifecta rate was 93%. CONCLUSIONS Sutureless retroperitoneal zero ischemia LPN for the treatment of low-complexity posterior renal masses showed to be safe and feasible. Longer follow-up and higher numbers of patients are, however, warranted to draw definitive conclusions on functional outcomes.
Collapse
|
24
|
Corongiu E, Grande P, Olivieri V, Pagliarella G, Forte F. Large primary leiomyosarcoma of the seminal vesicle: A case report and literature revision. Arch Ital Urol Androl 2019; 91:55-57. [DOI: 10.4081/aiua.2019.1.55] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/25/2018] [Accepted: 11/04/2018] [Indexed: 11/22/2022] Open
Abstract
Primary Leiomyosarcoma of the seminal vesicle is a very rare condition. We report a case of a 74-year-old man with a tumour detected by rectal symptoms with pelvic pain and dysuria at ultrasonography. Computed tomography and magnetic resonance imaging suggest an origin in the left seminal vesicle and did not show a clear cleavage plan with the rectum and a right hydroureteronephrosis was also present. A radical vesiculo-cystoprostatectomy with ileal conduit and bilateral pelvic lymphadenectomy was performed, a sigmoidectomy with end colostomy was performed also. Pathological examination showed a high grade (G3) leiomyosarcoma of the seminal vesicle.
Collapse
|
25
|
Corongiu E, Grande P, Olivieri V, Pagliarella G, Forte F. Minimally invasive management of a symptomatic case of Zinner's syndrome: Laparoscopic seminal vesiculectomy and ipsilateral nephroureterectomy. Arch Ital Urol Androl 2019; 91:58-59. [PMID: 30932434 DOI: 10.4081/aiua.2019.1.58] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/12/2019] [Accepted: 02/13/2019] [Indexed: 11/23/2022] Open
Abstract
INTRODUCTION Zinner syndrome is a rare developmental anomaly of the Wolffian (mesonephric) duct which is characterized by a triad of obstruction of the ejaculatory duct, the ipsilateral seminal vesicle cyst, and the ipsilateral renal agenesis. Usually is totally asymptomatic, however it can also determine symptoms such as lower urinary tract symptoms, perineal pain, ejaculatory disorders such as painful ejaculation or hematospermia, and infertility. CASE REPORT We present a case of a 51 years old men with a 3-year history of lower urinary tract symptoms, perineal pain, obstructed defecation, recurrent urinary tract infections and infertility. CT scan showed a voluminous cystic neoformation of the left seminal vesicle, hypoplasia of the left kidney and ipsilateral ureteronephrosis. The mass was removed using laparoscopic "en block" seminal vesiculectomy with associated ipsilateral nephroureterectomy. No post-operative complications occurred. At 2-month post-operative control the patient reported an improvement of urinary and rectal symptoms.
Collapse
|
26
|
Di Lorenzo L, Forte A, Forte F. Insight in spastic musculoskeletal structures in cerebral palsy: impaired or compensatory structural changes? Muscles Ligaments Tendons J 2019. [DOI: 10.32098/mltj.04.2013.19] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Affiliation(s)
- L. Di Lorenzo
- Rehabilitation Unit, Movement Disorders Treatment C., Neuroscience Department, “RUMMO” Hospital, Benevento, Italy
- Biomedical Research Centre, Gruppo Forte Salerno, Italy
| | - A.M. Forte
- Biomedical Research Centre, Gruppo Forte Salerno, Italy
| | - F. Forte
- Biomedical Research Centre, Gruppo Forte Salerno, Italy
| |
Collapse
|
27
|
Di Lorenzo L, Coco V, Forte F, Trinchese G, Forte A, Pappagallo M. The use of odds ratio in the large population-based studies: Warning to readers. Muscles Ligaments Tendons J 2019. [DOI: 10.32098/mltj.01.2014.16] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Affiliation(s)
- L. Di Lorenzo
- Rehabilitation Unit, Gait Analysis Lab, Neuroscience Department. “RUMMO” Hospital, Benevento, Italy Biomedical Research Centre, Gruppo Forte Salerno The New Medical Home for Pain Management and Medical Mentoring, New York, USA
| | - V. Coco
- Rehabilitation Unit, Gait Analysis Lab, Neuroscience Department. “RUMMO” Hospital, Benevento, Italy Biomedical Research Centre, Gruppo Forte Salerno The New Medical Home for Pain Management and Medical Mentoring, New York, USA
| | - F. Forte
- Rehabilitation Unit, Gait Analysis Lab, Neuroscience Department. “RUMMO” Hospital, Benevento, Italy Biomedical Research Centre, Gruppo Forte Salerno The New Medical Home for Pain Management and Medical Mentoring, New York, USA
| | - G.F.. Trinchese
- Rehabilitation Unit, Gait Analysis Lab, Neuroscience Department. “RUMMO” Hospital, Benevento, Italy Biomedical Research Centre, Gruppo Forte Salerno The New Medical Home for Pain Management and Medical Mentoring, New York, USA
| | - A.M. Forte
- Rehabilitation Unit, Gait Analysis Lab, Neuroscience Department. “RUMMO” Hospital, Benevento, Italy Biomedical Research Centre, Gruppo Forte Salerno The New Medical Home for Pain Management and Medical Mentoring, New York, USA
| | - M. Pappagallo
- Rehabilitation Unit, Gait Analysis Lab, Neuroscience Department. “RUMMO” Hospital, Benevento, Italy Biomedical Research Centre, Gruppo Forte Salerno The New Medical Home for Pain Management and Medical Mentoring, New York, USA
| |
Collapse
|
28
|
Russo GT, Giandalia A, Romeo EL, Scarcella C, Gambadoro N, Zingale R, Forte F, Perdichizzi G, Alibrandi A, Cucinotta D. Diabetic neuropathy is not associated with homocysteine, folate, vitamin B12 levels, and MTHFR C677T mutation in type 2 diabetic outpatients taking metformin. J Endocrinol Invest 2016; 39:305-14. [PMID: 26233336 DOI: 10.1007/s40618-015-0365-9] [Citation(s) in RCA: 31] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/31/2015] [Accepted: 07/20/2015] [Indexed: 01/01/2023]
Abstract
BACKGROUND Hyperhomocysteinemia and vitamin B12 deficiency may be involved in the development of diabetic peripheral neuropathy (DPN). Metformin therapy may reduce vitamin B12 plasma levels, thus contributing to DPN. AIM AND METHODS The purposes of this cross-sectional study were to assess (1) the potential associations of DPN with serum levels of homocysteine (tHcy), B-vitamins, and/or the common methylenetetrahydrofolate reductase (MTHFR) C677T mutation; (2) the influence of chronic treatment with metformin on tHcy and B-vitamins concentrations and, finally, (3) to evaluate whether, by this influence, metformin is a risk factor for DPN in a group of type 2 diabetic outpatients. RESULTS Our data showed that fasting tHcy, folate, and vitamin B12 levels and the MTHFR C677T genotype distribution were comparable between subjects with (n = 79, 30 %) and without DPN (n = 184, 70 %). Metformin-treated subjects (n = 124, 47 %) showed significantly lower levels of vitamin B12 (P < 0.001), but the prevalence of DPN was not different when compared to those not treated with this drug (33 vs. 27 %, P = NS). At univariate regression analysis, DPN was associated with age, duration of diabetes, HbA1c, creatinine levels, and the presence of coronary heart disease (CHD), and negatively with HDL-C concentrations (P < 0.05 all), but at multivariate regression analysis, high creatinine levels (P = 0.06), low HDL-C levels (P = 0.013), and a higher prevalence of CHD (P = 0.001) were the only variables independently associated with DPN in this population. CONCLUSIONS In conclusion, in these type 2 diabetic outpatients circulating levels of tHcy, folate, and the MTHFR C677T mutation are not associated with DPN, which was predicted by creatinine levels, CHD, and dyslipidemia. Metformin therapy is associated with a mild vitamin B12 level reduction, but not with DPN.
Collapse
Affiliation(s)
- G T Russo
- Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.
| | - A Giandalia
- Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy
| | - E L Romeo
- Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy
| | - C Scarcella
- Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy
| | - N Gambadoro
- Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy
| | - R Zingale
- Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy
| | - F Forte
- Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy
| | - G Perdichizzi
- Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy
| | - A Alibrandi
- Department of Economical, Business and Environmental Sciences and Quantitative Methods, University of Messina, Messina, Italy
| | - D Cucinotta
- Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy
| |
Collapse
|
29
|
Biganzoli L, Falbo A, Forte F, Grosso M, Rigamonti L. Mass balance and life cycle assessment of the waste electrical and electronic equipment management system implemented in Lombardia Region (Italy). Sci Total Environ 2015; 524-525:361-375. [PMID: 25913003 DOI: 10.1016/j.scitotenv.2015.04.041] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/18/2014] [Revised: 03/31/2015] [Accepted: 04/12/2015] [Indexed: 06/04/2023]
Abstract
Waste electrical and electronic equipment (WEEE) is one of the fastest growing waste streams in Europe, whose content of hazardous substances as well as of valuable materials makes the study of the different management options particularly interesting. The present study investigates the WEEE management system in Lombardia Region (Italy) in the year 2011 by applying the life cycle assessment (LCA) methodology. An extensive collection of primary data was carried out to describe the main outputs and the energy consumptions of the treatment plants. Afterwards, the benefits and burdens associated with the treatment and recovery of each of the five categories in which WEEE is classified according to the Italian legislation (heaters and refrigerators - R1, large household appliances - R2, TV and monitors - R3, small household appliances - R4 and lighting equipment - R5) were evaluated. The mass balance of the treatment and recovery system of each of the five WEEE categories showed that steel and glass are the predominant streams of materials arising from the treatment; a non-negligible amount of plastic is also recovered, together with small amounts of precious metals. The LCA of the regional WEEE management system showed that the benefits associated with materials and energy recovery balance the burdens of the treatment processes, with the sole exception of two impact categories (human toxicity-cancer effects and freshwater ecotoxicity). The WEEE categories whose treatment and recovery resulted more beneficial for the environment and the human health are R3 and R5. The contribution analysis showed that overall the main benefits are associated with the recovery of metals, as well as of plastic and glass. Some suggestions for improving the performance of the system are given, as well as an indication for a more-in-depth analysis for the toxicity categories and a proposal for a new characterisation method for WEEE.
Collapse
Affiliation(s)
- L Biganzoli
- Politecnico di Milano, Department of Civil and Environmental Engineering, Piazza L. da Vinci 32, 20133 Milano, Italy.
| | - A Falbo
- Politecnico di Milano, Department of Civil and Environmental Engineering, Piazza L. da Vinci 32, 20133 Milano, Italy
| | - F Forte
- Politecnico di Milano, Department of Civil and Environmental Engineering, Piazza L. da Vinci 32, 20133 Milano, Italy
| | - M Grosso
- Politecnico di Milano, Department of Civil and Environmental Engineering, Piazza L. da Vinci 32, 20133 Milano, Italy
| | - L Rigamonti
- Politecnico di Milano, Department of Civil and Environmental Engineering, Piazza L. da Vinci 32, 20133 Milano, Italy
| |
Collapse
|
30
|
Piscaglia AC, Ventura MT, Landolfo G, Giordano M, Russo S, Landi R, Zulian V, Forte F, Stefanelli ML. Chronic anisakidosis presenting with intestinal intussusception. Eur Rev Med Pharmacol Sci 2014; 18:3916-3920. [PMID: 25555884] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/04/2023]
Abstract
OBJECTIVE Anisakidosis is a parasitic infection caused by the ingestion of row or uncooked fish, containing larval nematodes from the Anisakidae family. Intestinal anisakidosis represents about 4% of all cases, the majority being localized in the small bowel, with rare colonic involvement. Here we present an infrequent case of chronic anisakidosis, presenting with intestinal intussusception. CASE REPORT A 52 years old woman, chronically treated with immunosuppressants, presented to our Institution with acute abdominal pain and vomiting, due to colocolic intussusception. Colonoscopy successfully reduced the intussusception and revealed the presence of a voluminous colonic submucosal mass, near the hepatic flexure. Therefore, the patient underwent laparoscopic right hemicolectomy. The diagnosis of anisakidosis was made when the histological examination of the surgical specimen revealed the infestation of the intestinal wall by a nematode of the Anisakidae family, with an intense erosive-inflammatory adjacent reaction.
Collapse
Affiliation(s)
- A C Piscaglia
- Gastroenterology and Endoscopy Unit, State Hospital, Republic of San Marino.
| | | | | | | | | | | | | | | | | |
Collapse
|
31
|
Morgia G, Castelli T, Cimino S, Favilla V, Fragalà E, Russo M, Carini M, Vespasiani G, Marchese F, Salvia G, Di Trapani D, Gentile M, Forte F, Masala A, Militello A, Mucciardi G, Barresi G. 1978 EFFECTS OF SERENOA REPENS, SELENIUM AND LYCOPENE ON CHRONIC INFLAMMATION ASSOCIATED WITH BPH: RESULTS OF A MULTICENTRE ITALIAN STUDY “FLOG” (FLOGOSIS AND PROFLUSS IN PROSTATIC AND GENITAL DISEASE). J Urol 2011. [DOI: 10.1016/j.juro.2011.02.2203] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
32
|
Braicovich L, Ament LJP, Bisogni V, Forte F, Aruta C, Balestrino G, Brookes NB, De Luca GM, Medaglia PG, Granozio FM, Radovic M, Salluzzo M, van den Brink J, Ghiringhelli G. Dispersion of magnetic excitations in the cuprate La2CuO4 and CaCuO2 compounds measured using resonant x-ray scattering. Phys Rev Lett 2009; 102:167401. [PMID: 19518752 DOI: 10.1103/physrevlett.102.167401] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/22/2008] [Indexed: 05/27/2023]
Abstract
By resonant inelastic x-ray scattering in the soft x-ray regime we probe the dynamical multiple-spin correlations in the antiferromagnetic cuprates La2CuO4 and CaCuO2. High resolution measurements at the copper L3 edge allow the clear observation of dispersing bimagnon excitations. Theory based on the ultrashort core-hole lifetime expansion fits the data on these coherent spin excitations without free parameters.
Collapse
Affiliation(s)
- L Braicovich
- CNR-INFM Coherentia and Soft, Dipartimento di Fisica, Politecnico di Milano, I-20133 Milano, Italy
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
33
|
Bronzetti E, Artico M, Forte F, Pagliarella G, Felici LM, D'Ambrosio A, Vespasiani G, Bronzetti B. A possible role of BDNF in prostate cancer detection. Oncol Rep 2008; 19:969-74. [PMID: 18357383 DOI: 10.3892/or.19.4.969] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022] Open
Abstract
Many studies have demonstrated that both normal and malignant prostate cells respond to a variety of growth factors, while several significant differences were found between normal and tumoural cells. The aim of this study was to focus on the localization and distribution of the immuno-reactivity for neurotrophins (NTs) and neurotrophin receptors (NTRs) in normal, hyperplastic and prostate cancer cells, obtained from 40 subjects. We studied samples obtained from 16 prostate cancer (PC, retropubic radical prostatectomy), 20 benign prostatic hyperplasia (BPH, supra-pubic prostatectomy) and normal peripheral prostate tissue from four fresh male cadavers. Samples were examined via immunohistochemical techniques in order to detect the expression of nerve growth factor (NGF), brain derived neurotrophic factor (BDNF), neurotrophin 3 (NT3) and their own receptors TrkA, p75, TrkB and TrkC. We observed a high expression of BDNF and TrkB in PC and BPH, though no immuno-reactivity was found for p75. Low expression was reported by other NTs and NTRs in the normal peripheral prostate zone, BPH and PC. These data suggest a possible predictive role for NTs and NTRs, especially for BDNF and TrkB, in the diagnosis and/or management of prostate cancer. The absence of p75 expression confirms its supposed role in apoptotic phenomenon.
Collapse
Affiliation(s)
- E Bronzetti
- Department of Cardiovascular, Respiratory and Morphological Sciences, University of Rome La Sapienza, Italy.
| | | | | | | | | | | | | | | |
Collapse
|
34
|
Varma S, Lacossiere K, Talwar J, Forte F, Dhar M. Renal epithelioid angiomyolipoma. J Clin Oncol 2008. [DOI: 10.1200/jco.2008.26.15_suppl.16134] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
35
|
Nakhl F, Elsoueidi R, Forte F, Lowry J, Burton J. A phase I/II trial of fixed-dose docetaxel plus irinotecan and escalating doses of estramustine phosphate for first-line or greater treatment of selected advanced solid tumors. J Clin Oncol 2008. [DOI: 10.1200/jco.2008.26.15_suppl.13522] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
36
|
Battisti C, Forte F, Molinelli M, Funghini S, Pasquini E, Tassini M, Dotti MT, Federico A. A new case of short-chain acyl-CoA dehydrogenase deficiency: clinical, biochemical, genetic and 1H-NMR spectroscopic studies. Neurol Sci 2008; 28:328-30. [DOI: 10.1007/s10072-007-0847-4] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/18/2007] [Accepted: 11/21/2007] [Indexed: 11/28/2022]
|
37
|
Bronzetti E, Artico M, Kovacs I, Felici LM, Magliulo G, Vignone D, D'Ambrosio A, Forte F, Di Liddo R, Feher J. Expression of neurotransmitters and neurotrophins in neurogenic inflammation of the rat retina. Eur J Histochem 2007; 51:251-260. [PMID: 18162454] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/25/2023] Open
Abstract
Antidromic stimulation of the rat trigeminal ganglion triggers the release of substance P (SP) and calcitonin gene-related peptide (CGRP) from sensory nerve terminals of the capsaicin sensitive C-fibers. These pro-inflammatory neuropeptides produce a marked hyperemia in the anterior segment of the eye, accompanied by increased intraocular pressure, breakdown of the blood-aqueous barrier and myosis. To assess the effects of neurogenic inflammation on the retina, specifically on the immunostaining of neurotransmitters and neurotrophins, as well as on the expression of neurotrophin receptors in the retina. RT-PCR was also accomplished in control and stimulated animals to confirm the immunohistochemical results. In the electrically stimulated eyes, immunostaining for SP, CGRP, VIP and nNOS demonstrated a marked increase in the RPE/POS (Retinal Pigment Epithelium/Photoreceptor Outer Segments), in the inner and outer granular layers and in the ganglion cells in comparison to the control eyes. CGRP and SP were found increased in stimulated animals and this result has been confirmed by RT- PCR. Changes in neurotrophin immunostaining and in receptor expression were also observed after electric stimulation of trigeminal ganglia. Decrease of BDNF and NT4 in the outer and inner layers and in ganglion cells was particularly marked. In stimulated rat retinas immunostaining and RT-PCR showed a NGF expression increase. Neurotrophin receptors remained substantially unchanged. These studies demonstrated, for the first time, that antidromic stimulation of the trigeminal ganglion and subsequent neurogenic inflammation affect immunostaining of retinal cell neurotransmitter/neuropeptides and neurotrophins as well as the expression of neurotrophin receptors.
Collapse
Affiliation(s)
- Elena Bronzetti
- Department of Cardiovascular, Respiratory and Morphological Sciences, G Ferreri University of Rome La Sapienza, Via A. Borelli 50 - 00161 Rome Italy
| | | | | | | | | | | | | | | | | | | |
Collapse
|
38
|
Artico M, Bronzetti E, Saso L, Felici LM, D'Ambrosio A, Forte F, Grande C, Ortolani F. Immunohistochemical profile of some neurotransmitters and neurotrophins in the seminiferous tubules of rats treated by lonidamine. Eur J Histochem 2007; 51:19-24. [PMID: 17548265] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/15/2023] Open
Abstract
Lonidamine (LND) or [1-(2,4-dichlorobenzyl)-1H-indazole-3-carboxylic acid] is an anticancer and antispermatogenic drug that exerts a large number of effects on tumor cells and germ cells. Sexually mature male Sprague-Dawley rats were housed at 22 degrees C on a 12-h light/12-h dark cycle 1 week before the experiments, with free access to food and water. LND was suspended in 0.5% methylcellulose at a concentration of 10 mg/mL and administered orally at the dose of 10 mL/kg (b.w.) as a single dose. Control rats received an equal amount of vehicle. Testes were removed, fixed for 24 h in 2% glutaraldehyde and 2% paraformaldehyde in 0.1 M sodium phosphate (pH 7.2 at 22 degrees C), rinsed with the same buffer, and stored at room temperature. From each sample, a block of tissue was removed by sectioning through the organ. After dehydration in ethanol at increasing concentrations (70-100%), each block was embedded in paraffin and serial 5 mm thick sections were cut using a rotatory microtome. The immunoreactivity for NTs has been observed in spermatogonia of untreated rats, while the rats treated with LND showed an immunohistochemical localization in all the stages of germinal cells. The generally well-expressed immunoreactivity for the neurotrophins receptors in treated rats observed in our study is presumably attributable to alterations of the receptors' structure and/or expression leading to changes of the activity, affinity, localization or protein interactions that may depend on sensitization of ion channels (induced by LND). Neurotrophins (NTs) appear to be interesting proteins for the modulation of sperm maturation and motility with a prominent role for the nerve growth factor (NGF), that may exert an autocrine or paracrine role. We therefore investigated the location and distribution of immunoreactivity for some neurotransmitters (SP, VIP, CGRP, nNOS, Chat), neurotrophins (NGF, BDNF, NT-3) and their own receptors (TrKA, TrKB, TrKC, p75) in the seminiferous tubules of male rats treated by LND in the light of the literature on this topic.
Collapse
Affiliation(s)
- M Artico
- Department of Human Physiology and Pharmacology, V. Erspamer University of Rome La Sapienza, P.le Aldo Moro, 5 00185 Rome, Italy.
| | | | | | | | | | | | | | | |
Collapse
|
39
|
Forte F, Strobl RO, Pennetta L. A methodology using GIS, aerial photos and remote sensing for loss estimation and flood vulnerability analysis in the Supersano-Ruffano-Nociglia Graben, southern Italy. ACTA ACUST UNITED AC 2006. [DOI: 10.1007/s00254-006-0234-0] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
40
|
Odaimi M, Farah R, Terjanian T, Vesoniaraki M, Friscia P, Rubin A, Dhar M, Dai Q, Forte F, Burton J. Updated results of a phase II trial of therapy with cyclophosphamide (CYP)/pentostatin/rituximab for indolent NHL and CLL. J Clin Oncol 2005. [DOI: 10.1200/jco.2005.23.16_suppl.6713] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
- M. Odaimi
- Staten Island Univ Hosp, Staten Island, NY; St. Joseph’s Medcl Ctr, Paterson, NJ
| | - R. Farah
- Staten Island Univ Hosp, Staten Island, NY; St. Joseph’s Medcl Ctr, Paterson, NJ
| | - T. Terjanian
- Staten Island Univ Hosp, Staten Island, NY; St. Joseph’s Medcl Ctr, Paterson, NJ
| | - M. Vesoniaraki
- Staten Island Univ Hosp, Staten Island, NY; St. Joseph’s Medcl Ctr, Paterson, NJ
| | - P. Friscia
- Staten Island Univ Hosp, Staten Island, NY; St. Joseph’s Medcl Ctr, Paterson, NJ
| | - A. Rubin
- Staten Island Univ Hosp, Staten Island, NY; St. Joseph’s Medcl Ctr, Paterson, NJ
| | - M. Dhar
- Staten Island Univ Hosp, Staten Island, NY; St. Joseph’s Medcl Ctr, Paterson, NJ
| | - Q. Dai
- Staten Island Univ Hosp, Staten Island, NY; St. Joseph’s Medcl Ctr, Paterson, NJ
| | - F. Forte
- Staten Island Univ Hosp, Staten Island, NY; St. Joseph’s Medcl Ctr, Paterson, NJ
| | - J. Burton
- Staten Island Univ Hosp, Staten Island, NY; St. Joseph’s Medcl Ctr, Paterson, NJ
| |
Collapse
|
41
|
Burton JD, El-Sayah D, Cherry M, Bhargava M, Terjanian T, Odaimi M, Vesoniaraki M, Lowry J, Forte F, Friscia P. Results of a phase I/II trial of carboplatin/gemcitabine plus celecoxib for first-line treatment of stage IIIB/IV non-small cell lung cancer (NSCLC). J Clin Oncol 2005. [DOI: 10.1200/jco.2005.23.16_suppl.7250] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
| | | | - M. Cherry
- Staten Island Univ Hosp, Staten Island, NY
| | | | | | - M. Odaimi
- Staten Island Univ Hosp, Staten Island, NY
| | | | - J. Lowry
- Staten Island Univ Hosp, Staten Island, NY
| | - F. Forte
- Staten Island Univ Hosp, Staten Island, NY
| | - P. Friscia
- Staten Island Univ Hosp, Staten Island, NY
| |
Collapse
|
42
|
Virgili G, Forte F, Sansalone S, Attisani F, De Carolis A, Di Stasi SM, Vespasiani G. Radical prostatectomy as unique chance for huge prostatic stones. Arch Ital Urol Androl 2004; 76:171-2. [PMID: 15693432] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/01/2023] Open
Abstract
Prostatic calculi occur very often in men, but exceptionally they cause an almost total destruction of the prostatic parenchyma. Preferred treatment in order to obtain complete resolution is either transurethral resection or suprapubic simple prostatectomy. We report for the first time a radical prostatectomy as a unique chance for huge prostatic stones in a 56-years old man with severe urinary symptoms. We perform a retropubic radical prostatectomy using a nerve sparing technique. There were no intraoperative or postoperative complications. Though radical prostatectomy is an invasive approach to treat a young man affected by prostatic stones and without prostate cancer, we chose to perform it because of the impossibility to obtain complete recovery with transurethral or suprapubic simple prostatectomy.
Collapse
Affiliation(s)
- Guido Virgili
- Department of Urology, University of Rome Tor Vergata, Rome, Italy
| | | | | | | | | | | | | |
Collapse
|
43
|
Forte F, Scarfini M, Spera E, De Carolis A, Sansalone S, Virgili G, Vespasiani G. Leiomyoma of the epididymis and testicular adnexa: apropos of 3 cases. Arch Ital Urol Androl 2004; 76:119-20. [PMID: 15568302] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/01/2023] Open
Abstract
The intrascrotal benign tumours are rare and are generally defined as arising between didymis and spermatic cord. Among the benign tumours of the epididymis and testicular adnexa, leiomyoma is second most common. Three cases of intrascrotal leiomyoma are reported: two originating from the epididymis and one from the epididymis and tunica vaginalis.
Collapse
Affiliation(s)
- Flavio Forte
- Department of Urology, University of Rome "Tor Vergata", Rome, Italy.
| | | | | | | | | | | | | |
Collapse
|
44
|
Burton JD, Badine E, El-Sayah D, Dib E, Forte F, Terjanian T, Odaimi M, Vesoniaraki M, Friscia P, Lowry J. Update of a phase I/II trial of carboplatin/gemcitabine plus escalating doses of celecoxib for first-line treatment of stage IIIB/IV non-small cell lung cancer (NSCLC). J Clin Oncol 2004. [DOI: 10.1200/jco.2004.22.90140.7339] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
- J. D. Burton
- Staten Island University Hospital, Staten Island, NY
| | - E. Badine
- Staten Island University Hospital, Staten Island, NY
| | - D. El-Sayah
- Staten Island University Hospital, Staten Island, NY
| | - E. Dib
- Staten Island University Hospital, Staten Island, NY
| | - F. Forte
- Staten Island University Hospital, Staten Island, NY
| | - T. Terjanian
- Staten Island University Hospital, Staten Island, NY
| | - M. Odaimi
- Staten Island University Hospital, Staten Island, NY
| | | | - P. Friscia
- Staten Island University Hospital, Staten Island, NY
| | - J. Lowry
- Staten Island University Hospital, Staten Island, NY
| |
Collapse
|
45
|
Odaimi M, El-Jassous I, Richa E, Forte F, Terjanian T, Vesoniaraki M, Lowry J, Murukutla S, Dhar M, Burton J. Phase I/II trial of a novel regimen of GM-CSF, IL-2 and pegylated interferon-alpha2b (PEG-Intron) for stage IV melanoma and renal cell carcinoma (RCC). J Clin Oncol 2004. [DOI: 10.1200/jco.2004.22.90140.7573] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
- M. Odaimi
- Staten Island University Hospital, Staten Island, NY
| | - I. El-Jassous
- Staten Island University Hospital, Staten Island, NY
| | - E. Richa
- Staten Island University Hospital, Staten Island, NY
| | - F. Forte
- Staten Island University Hospital, Staten Island, NY
| | - T. Terjanian
- Staten Island University Hospital, Staten Island, NY
| | | | - J. Lowry
- Staten Island University Hospital, Staten Island, NY
| | - S. Murukutla
- Staten Island University Hospital, Staten Island, NY
| | - M. Dhar
- Staten Island University Hospital, Staten Island, NY
| | - J. Burton
- Staten Island University Hospital, Staten Island, NY
| |
Collapse
|
46
|
Falvo L, Berni A, Catania A, Dibra A, Foti N, Sorrenti S, De Stefano M, Forte F, Palermo S, De Antoni E. Synchronous bilateral renal tumour: a case report. Chir Ital 2004; 56:271-4. [PMID: 15152522] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 04/29/2023]
Abstract
We report a case of synchronous bilateral renal carcinoma treated by partial nephrectomy on the right and total nephrectomy on the left. Follow-up at 42 months after surgery showed no recurrence of the disease. The increasing use of diagnostic imaging techniques such as ultrasound tomography, computerised tomography and nuclear magnetic resonance now allows even small-sized renal formations to be identified. Synchronous bilateral renal tumour has a favourable prognosis, especially when compared with single or asynchronous renal tumours. The recommended intervention is total monolateral nephrectomy combined with partial nephrectomy. The treatment of neoplasms at a more advanced stage, of such a nature as to necessitate bilateral nephrectomy or chemotherapy, results in a significant increase in mortality. Recently, biological therapy has been proposed as a more promising short-term option using interferon-alpha (IFN-alpha) and gamma.
Collapse
Affiliation(s)
- Laura Falvo
- Divisione di Chirurgia Generale, Dipartimento di Scienze Chirurgiche-Università degli Studi La Sapienza di Roma
| | | | | | | | | | | | | | | | | | | |
Collapse
|
47
|
Maturo G, Vespasiani G, Mohamed EI, Maiolo C, Finazzi Agrò E, Forte F, De Lorenzo A. Evaluating body composition of Italian prostate cancer patients without metastases. Acta Diabetol 2003; 40 Suppl 1:S168-70. [PMID: 14618463 DOI: 10.1007/s00592-003-0056-4] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
Abstract
Prostate cancer (PCa) is becoming an increasingly important public health problem worldwide, and anthropometric studies have revealed that body composition is a potential risk factor for this type of cancer. The objective of the present study was to compare Italians with PCa and no history of androgen deprivation therapy or bone metastases with healthy controls in terms of body composition. We recruited 11 PCa patients [mean age (+/-SD), 68.67+/-4.93 years; body mass index (BMI), 28.42+/-2.96 kg/m(2)] and 11 healthy controls matched for age and BMI. Anthropometric and body composition parameters were measured for all participants using dual X-ray absorptiometry and bioelectric impedance analysis techniques. We found that lean body mass, but not fat mass, was significantly lower for PCa patients in comparison with healthy controls (50.24+/-5.03 vs. 53.63+/-5.61 kg, p<0.05). Thus, PCa patients with no history of androgen deprivation therapy and no bone metastasis suffer muscle mass depletion.
Collapse
Affiliation(s)
- G Maturo
- Division of Urology Policlinico Casilino, University of Tor Vergata, Via Casilina 1049, I-00169, Rome, Italy.
| | | | | | | | | | | | | |
Collapse
|
48
|
Forte F, Sorrenti S, Felici LM, Carbotta S, Foti N, Falvo L, Vanni B, Biancafarina A, Catania A, Bronzetti E. [Ontogenesis of congenital abnormalities of the left gonadal vein and their clinical relevance]. Chir Ital 2003; 55:417-24. [PMID: 12872579] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 03/03/2023]
Abstract
The anatomy of the gonadal vein has been the subject of several studies relating particularly to the aetiology and therapy of varicocele and left ovarian vein syndrome. Venography shows the presence of valves, the collateral branches, the anastomoses between the left gonadal vein and the retroperitoneal venous networks and the effective pathways of venous reflux. The authors observed a particular congenital anomaly of the left gonadal vein in the dissection of a female cadaver, and studied the venographic pattern of a male patient with left idiopathic varicocele. The aim of this study was to investigate, with the aid of a review of the literature, the embryo-pathogenetic basis of congenital abnormalities of the left gonadic vein, stressing those factors most conducive to errors in the diagnosis and therapy of varicocele and left ovarian vein syndrome, particularly in the scleroembolisation therapy of idiopathic varicocele.
Collapse
Affiliation(s)
- Flavio Forte
- Cattedra di Urologia, Università di Roma Tor Vergata
| | | | | | | | | | | | | | | | | | | |
Collapse
|
49
|
Germani S, Miano R, Forte F, Finazzi Agrò E, Virgili G, Vespasiani G. Acute lumbago and sciatica as first symptoms of focal xanthogranulomatous pyelonephritis. Urol Int 2003; 69:247-9. [PMID: 12372898 DOI: 10.1159/000063938] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
Xanthogranulomatous pyelonephritis (XGP) is a rare inflammatory disease of the kidney, presenting in a diffuse or focal form. The preoperative diagnosis of XGP is made only in 10% of the cases because neither the clinical nor the radiological presentation are specific and could be confused with renal tumors, thus deserving the name of 'great imitator'. We report a case of focal XGP in a middle-aged man presenting with acute lumbago and sciatica, an unusual clinical presentation.
Collapse
Affiliation(s)
- Stefano Germani
- Department of Urology, University of Tor Vergata, Rome, Italy.
| | | | | | | | | | | |
Collapse
|
50
|
Forte F, Bitelli M, Sorrenti S, Spinelli GL, Foti N, Ciotola O, Pietrantuono F, Catania A, Micali F. Testicular fixation in adult retractile testis: technical notes. Chir Ital 2003; 55:145-7. [PMID: 12633055] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 03/01/2023]
Abstract
A variety of techniques for scrotal orchiopexy have been described in the literature, including those without suture fixation, such as the scrotal pouch. We perform a simple modified technique for bilateral testicular fixation in patients with bilateral and/or unilateral adult retractile testis and with symptoms characterised by chronic orchialgia due to testicular hypermobility or repeated funicular subtorsion.
Collapse
Affiliation(s)
- Flavio Forte
- Department of Urology, University of Rome Tor Vergata, Operative Unit of Urology, Ospedale Israelitico, Rome
| | | | | | | | | | | | | | | | | |
Collapse
|